Old Web
English
Sign In
Acemap
>
authorDetail
>
Jill Maaske
Jill Maaske
AstraZeneca
Medicine
Metformin
Glimepiride
Dapagliflozin
Saxagliptin
3
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: Results of a 104-week extension to a 52-week randomized, phase 3 study and liver fat MRI substudy.
2021
Diabetes, Obesity and Metabolism
Juan P. Frias
Jill Maaske
Lisa J. Suchower
Lars Johansson
Paul D. Hockings
Nayyar Iqbal
John P H Wilding
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial
2020
Diabetes, Obesity and Metabolism
Juan P. Frias
Guillermo Gonzalez‐Galvez
Eva Johnsson
Jill Maaske
Marcia A. Testa
Donald C. Simonson
Nalina Dronamraju
Ricardo Garcia‐Sanchez
Anne L. Peters
Show All
Source
Cite
Save
Citations (3)
Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes
2020
Diabetes, Obesity and Metabolism
Lars Johansson
Paul D. Hockings
Eva Johnsson
Nalina Dronamraju
Jill Maaske
Ricardo Garcia‐Sanchez
John P H Wilding
Show All
Source
Cite
Save
Citations (11)
1